This message was sent to ##Email##
|
|
|
|
|
HealthDay News
Researchers say they're closer to developing a blood test that distinguishes between viral and bacterial respiratory infections. This would help doctors predict when antibiotics will and will not work.
Such a test, done right in the doctor's office, might also help curb overuse of antibiotics — a practice that has led to drug-resistant bacteria, experts suggest.
READ MORE
ASCLS
 Join ASCLS, CLMA, ASCP, AMT and AGT for the annual Legislative Symposium. Spend a day learning about issues affecting the clinical laboratory. Then visit Capitol Hill to discuss these issues with members of Congress. The event will be held March 14-15 at the Hilton Old Town in Alexandria, Virginia. Register by Feb. 15 to receive special early bird pricing. Visit www.ascls.org/events for more information.
READ MORE
|
Promoted by
|
|
|
|
 |
Vanderbilt University Medical Center via Infection Control Today
There may be a "silver bullet" for Ebola, a family of hemorrhagic viruses, one of which has killed more than 11,000 people in West Africa in the past two years. Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch in Galveston reported in the journal Cell that they have isolated human monoclonal antibodies from Ebola survivors which can neutralize multiple species of the virus.
READ MORE
DARK Daily
Clinical laboratories and biotech companies with new medical laboratory tests are struggling to win coverage by Medicare and private payers. How big is this problem? There are currently tens of thousands of molecular diagnostic assays and genetic tests offered for clinical use.
READ MORE
PRODUCT SHOWCASE
Medical News Today
The majority of colon cancer patients whose tumors have started to travel to nearby tissue but no further are cured by surgery alone. But in a minority of these stage 2 colon cancer cases, the cancer returns and the patients die. Now, researchers have found a genetic biomarker that appears to predict which stage 2 colon cancer patients might benefit from post-surgery chemotherapy to prevent relapse.
READ MORE
Reuters
U.S. farm and health officials are racing to assess the threat that a type of bird flu never before seen in the country poses to humans and poultry, employing emergency plans drawn up in the wake of a devastating outbreak in birds last year. The federal government sprang into action after confirmation overnight that the virus had hit an Indiana turkey farm, alerting other states to the danger and putting workers who might have been exposed to the virus under surveillance.
READ MORE
PRODUCT SHOWCASE
 |
|
ZeptoMetrix Corporation (ZMC) is an Industry leader and innovator identified with quality, reliable and trusted Products and Services for Infectious Disease Diagnostic Development. From assay conception to launch, our Scientific and Operational Teams provide our Customers with cohesive, inventive and cost effective solutions.
Learn More
|
|
Helmholtz Association of German Research Centres via Phys.org
Human stem cells that are capable of becoming any other kind of cell in the body have previously only been acquired and cultivated with difficulty. Scientists at the Max Delbrück Center for Molecular Medicine in the Helmholtz Association have now presented details of a method to detect such pluripotent cells in a cell culture and preserve them in the laboratory.
READ MORE
Monash University via Lab Manager
New research led by a team of scientists from Monash University and the University of Bristol has resulted in the development of a blueprint that will eventually allow clinicians to routinely turn cells in the human body into tissues needed to treat disease. Applications include turning skin cells into cells of the arteries and veins to treat people with diabetes or heart disease.
READ MORE
 |
|
It’s like having my own Flow cytometry lab at my finger tips. Finally, a simple way to bring flow cytometry CD4 testing in-house. MORE
|
|
Dartmouth College via ScienceDaily
Nerve damage from neurodegenerative disease and spinal cord injury has largely been considered irreversible, but researchers now report progress in the effort to synthesize rare natural products that promote regeneration and growth of injured nerve cells.
READ MORE
Health Canal
Cardiff University scientists are part of a U.K. team to develop a simple blood test capable of detecting levels of leukemia cells remaining after intensive chemotherapy. The test helps predict which patients with acute myeloid leukemia are at risk of their cancer returning in the future, helping to guide doctors on what further treatment is needed.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
